Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

14 treatments under study, led by Acrysof Panoptix Trifocal Iol

Research Leaders

10 sponsors active, led by Bucci Laser Vision Institute

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 10 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed6
Unknown4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 6 completed trials

Clinical Trials (10)

Research Network

Common Treatments

  • Acrysof Panoptix Trifocal Iol1
  • Intraocular Lenses1
  • At Torbi 709m1
  • Light Adjustable Lens1
  • Implantation Of Synthesis Plus Iol Control Device1

Active Sponsors

  • Bucci Laser Vision Institute2
  • Enrique Ordiñaga-Monreal, OD, MSc1
  • Seoul National University Hospital1
  • Vold Vision P.L.L.C1
  • Cutting Edge SAS1

Top Investigators

Related Conditions

  • Cataract6
  • Astigmatism3
  • Cataract Congenital1
  • Cornea Abnormality1
  • Surgery1

Activity Timeline